Evidence map›Paper›PMID 26142221›Full record

ArticleAnalytical biochemistry2015

An improved intrafemoral injection with minimized leakage as an orthotopic mouse model of osteosarcoma.

Hiromi Sasaki, Swathi V Iyer, Ken Sasaki, Ossama W Tawfik, Tomoo Iwakuma

Abstract read
In one paragraph

Article in Analytical biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. A Mouse Model of Cancer Induced Bone Pain: From Pain to Movement.Frontiers in behavioral neuroscience · 2022
    Article
  4. Article
  5. The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiromi SasakiDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Swathi V IyerDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Ken SasakiDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Ossama W TawfikDepartment of Pathology, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Tomoo IwakumaDepartment of Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: tiwakuma@kumc.edu.

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Center for Cancer Experimental TherapeuticsP30GM103495 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI TIMMERMANN, BARBARA N · 2012 to 2014
$3.2M
The role of MDM2-MTBP axis in cancer metastasisR01CA174735 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI IWAKUMA, TOMOO · 2014 to 2018
$1.6M
NCI NIH HHS 1-R01-CA174735-01A1NCI NIH HHS 5-P30-CA168524-02NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA174735NIGMS NIH HHS 8-P30-GM103495NIGMS NIH HHS P30 GM103495
6 · The paper itself

Abstract

Osteosarcoma, the most common type of primary bone cancer, is the second highest cause of cancer-related death in pediatric patients. To understand the mechanisms behind osteosarcoma progression and to discover novel therapeutic strategies for this disease, a reliable and appropriate mouse model is essential. For this purpose, osteosarcoma cells need to be injected into the bone marrow. Previously, the intratibial and intrafemoral injection methods were reported; however, the major drawback of these methods is the potential leakage of tumor cells from the injection site during or after these procedures. To overcome this, we have established an improved method to minimize leakage in an orthotopic mouse model of osteosarcoma. By taking advantage of the anatomical benefits of the femur with less bowing and larger medullary cavity than those of the tibia, osteosarcoma cells are injected directly into the femoral cavity following reaming of its intramedullary space. To prevent potential leakage of tumor cells during and after the surgery, the injection site is sealed with bone wax. This method requires a minor surgery of approximately 15min under anesthesia. Our established orthotopic osteosarcoma model could serve as a valuable and reliable tool for examining progression of various types of bone tumors.

Indexed as

Cell Transformation, NeoplasticFemurAnimalsBone NeoplasmsCell Line, TumorDisease Models, AnimalHumansInjectionsMiceOsteosarcomaIntrafemoralLeakMetastasisMouse modelOrthotopicOsteosarcoma

Identifiers

PMID26142221
PMCPMC4537805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.